Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Dalerba

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2007
Phenotypic characterization of human colorectal cancer stem cellsPiero Dalerba, Scott J Dylla, In-Kyung Park, et al.
Cell|August 12, 2009
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cellsYohei Shimono, Maider Zabala, Robert W Cho, et al.
International Journal of Cancer|August 15, 2024
Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritoneiNayana Lazzari, Giulia Rigotto, Barbara Montini, et al.
Cancer Research|March 23, 2005
Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cellsPiero Dalerba, Cristiana Guiducci, Pietro Luigi Poliani, et al.
Journal of Gastroenterology|March 4, 2022
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cellsShigeo Hisamori, Junko Mukohyama, Sanjay Koul, et al.
Journal of the National Cancer Institute|March 6, 2015
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomideManuela Cominelli, Salvatore Grisanti, Stefania Mazzoleni, et al.
The New England Journal of Medicine|January 21, 2016
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerPiero Dalerba, Debashis Sahoo, Soonmyung Paik, et al.
Elife|November 19, 2014
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathwayTaichi Isobe, Shigeo Hisamori, Daniel J Hogan, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination TherapyJeremy Worley, Heeju Noh, Daoqi You, et al.
PNAS Nexus|June 5, 2023
Eric Wu, Alexandro E Trevino, Zhenqin Wu, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2007
Phenotypic characterization of human colorectal cancer stem cellsPiero Dalerba, Scott J Dylla, In-Kyung Park, et al.
Cell|August 12, 2009
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cellsYohei Shimono, Maider Zabala, Robert W Cho, et al.
International Journal of Cancer|August 15, 2024
Stemness and hybrid epithelial-mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritoneiNayana Lazzari, Giulia Rigotto, Barbara Montini, et al.
Cancer Research|March 23, 2005
Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cellsPiero Dalerba, Cristiana Guiducci, Pietro Luigi Poliani, et al.
Journal of Gastroenterology|March 4, 2022
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cellsShigeo Hisamori, Junko Mukohyama, Sanjay Koul, et al.
Journal of the National Cancer Institute|March 6, 2015
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomideManuela Cominelli, Salvatore Grisanti, Stefania Mazzoleni, et al.
The New England Journal of Medicine|January 21, 2016
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerPiero Dalerba, Debashis Sahoo, Soonmyung Paik, et al.
Elife|November 19, 2014
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathwayTaichi Isobe, Shigeo Hisamori, Daniel J Hogan, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination TherapyJeremy Worley, Heeju Noh, Daoqi You, et al.
PNAS Nexus|June 5, 2023
Eric Wu, Alexandro E Trevino, Zhenqin Wu, et al.
Pageof 5